Tacrolimus intrapatient variability (IPV) also showed a decreasing trend, from 26.45% in 2019 to 18.7% in 2022.
← all excerpts
A quality improvement initiative for achieving target tacrolimus concentration in renal transplant recipients: A quality improvement article.
1
—
—